Clin2
NCT07239310Possibly a fitRecruiting

Device to improve memory and thinking in early Alzheimer's

Mild Cognitive ImpairmentAlzheimer's Disease(AD)

Part of Brain & nervous system, Mental health clinical trials.

This study tests a device called Neuclare that aims to temporarily boost memory and thinking skills in people with mild cognitive impairment or very early Alzheimer's disease. It could offer a non-drug way to help with daily mental tasks.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
138 people
Ages
55 years to 90 years
Study type
Interventional

Who can take part

  • You are between 55 and 90 years old.
  • You have been diagnosed with mild cognitive impairment or early Alzheimer's disease.
  • Your thinking problems are mild to moderate (a score of 0.5 to 1 on the CDR scale and at least 18 on a standard memory test).
  • You have been on the same memory medication for at least a month.
  • You do not have brain injury or conditions like tumors or bleeding, and you can undergo an MRI scan.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05887674Recruiting
Non-drug memory program for early Alzheimer’s and memory loss

This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.

Shanghai, Shanghai Municipality
NCT05904132Recruiting
Brain stimulation therapy for early Alzheimer’s memory loss

This trial studies a “closed-loop” brain stimulation approach to improve symptoms in people with early Alzheimer’s-related memory problems. It may help by delivering stimulation based on your brain signals, if you meet the safety and diagnosis requirements.

Charlestown, Massachusetts
NCT07243600Recruiting
Brain Training for Memory in Mild Cognitive Impairment

This study tests a computer-based brain-training program designed to improve memory and thinking skills in older adults with mild cognitive impairment (MCI). It aims to see if these exercises can help keep the brain healthy and slow down memory decline.

Montreal, Quebec
NCT06761066Enrolling by invitation
Testing NVP-NK4146 for mild cognitive impairment due to Alzheimer's

This study tests a new medicine, NVP-NK4146, for people with mild cognitive impairment (MCI) due to Alzheimer's disease. The goal is to see if it can help slow down memory and thinking problems.

Seoul
NCT07262645Recruiting· Phase 3
Light therapy for mild Alzheimer's disease

This study tests if a near-infrared light therapy device can help improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves daily treatment sessions with the device, and a study partner must be available to help with treatment.

Beijing, Beijing Municipality
NCT07214974Not yet recruiting· Early Phase 1
Stem cell and brain device study for mild memory loss

This study tests a new approach for people with mild memory problems using stem cell therapy and a wearable brain-computer device. The goal is to see if these treatments can help improve or slow down memory decline.

Palisades Park, New Jersey

Hear when a new Mild Cognitive Impairment trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.